Sioux Pharm Inc.

SIOUX PHARM INC., should be restrained from making any statements likely to discredit the Applicant, SUMMIT NUTRITIONALS INTERNATIONAL INC., and its product and be further restrained from introducing Chondroitine Sulphate into the European market that does not comply fully with the purity requirement of at least 90% of this product and, in the case of pharmaceutical grade chondroitine sulphate, which does not comply with the other requirements applicable to that grade of product.

Official Court Documents

SNI vs. Sioux Pharm – 1

SNI vs. Sioux Pharm – 2

SNI vs. Sioux Pharm – 3

SNI vs. Sioux Pharm – 4

SNI vs. Sioux Pharm – 5

Author: jaime

Share This Post On